Civic AI
Procurement intelligence
Federal contract award
THIS IS SERVICE FOR PHASE 1/PHASE 2 OPEN LABEL TRIAL OF A NOVEL INDENOISOQUINOLONE CMYC/TOPOISOMERASE 1 INHIBITOR (LMP744) IN RECURRENT GLIOBLASTOMA. POP: 02/06/2026 TO 02/05/2027.
MEDICAL RESEARCH SUPPORT LLC · Department of Health and Human Services
- Value
- $21,450
- Start
- Feb 6, 2026
- End
- Feb 5, 2027
- Action date
- Feb 6, 2026
- PIID
- 75N95A26P00038
- Status
- active
- NAICS
- 518210 · COMPUTING INFRASTRUCTURE PROVIDERS, DATA PROCESSING, WEB HOSTING, AND RELATED SERVICES
- Place of performance
- GAITHERSBURG, MD
- Award type
- PURCHASE ORDER
Description
THIS IS SERVICE FOR PHASE 1/PHASE 2 OPEN LABEL TRIAL OF A NOVEL INDENOISOQUINOLONE CMYC/TOPOISOMERASE 1 INHIBITOR (LMP744) IN RECURRENT GLIOBLASTOMA. POP: 02/06/2026 TO 02/05/2027.
Need modifications, related awards, and vendor peers? Open the full award workspace.